Get the latest tech news
With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon
Nuravax and others are working on the next wave of Alzheimer’s treatments to catch the disease before symptoms arise.
Along the way, those drugs, such as Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla, and now a newly cleared blood test for signs of Alzheimer’s, have paved the road for a potential gamechanger in years to come: a vaccine. That capability could bring new treatment options to potentially stop the disease before symptoms arise, said Roman Kniazev, CEO of the biotech Nuravax, which is in the early stages of Alzheimer’s vaccine development. While the company, which got its start in 2021, is preparing to launch human trials, Kniazev is convinced a vaccine approach is particularly suited for Alzheimer’s because it can be used earlier in a patient’s journey with minimal side effects.
Or read this on r/technology
